Simultaneously, the absence of significant suppression of migratory activity highlights the necessity for supplementary targeting of alternative signaling cascades, such as FAK/Src and MAPK, to effectively curtail the invasive potential of RA-FLSs. The gene discussed is SRC; the disease is rheumatoid arthritis.